5-hydroxymethyl-2-furfuraldehyde | |
---|---|
Trade Name | |
Orphan Indication | Sickle cell anemia |
USA Market Approval | USA |
USA Designation Date | 2006-05-26 00:00:00 |
Sponsor | Baxalta US, Inc.;ONe Baxter Way;Westlake Village, California, 91362 |
Related Access Program